<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03100292</url>
  </required_header>
  <id_info>
    <org_study_id>B-1608/357-005</org_study_id>
    <nct_id>NCT03100292</nct_id>
  </id_info>
  <brief_title>Korean OBEsity Surgical Treatment Study</brief_title>
  <acronym>KOBESS</acronym>
  <official_title>Efficacy and Safety of Bariatric Surgery for Korean Morbidly Obese Patients : Prospective Multicenter Cohort Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Bundang Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ministry of Health &amp; Welfare, Korea</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Seoul National University Bundang Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      This trial is a multi-center, single-arm, prospective, observational cohort study of patients
      undergoing primary bariatric surgical procedures in Korea. A total of 100 patients will be
      recruited over a 1-year period from 2016 to 2017, and will be followed for a mean follow-up
      period of 1 year after surgery. The eligible subjects who have given their consent to
      participate will undergo one of two surgical procedures; sleeve gastrectomy and Roux-en Y
      gastric bypass.

      The primary objective of this clinical trial is to measure the changes in body weight (kg)
      and waist circumference (cm) of the enrolled patients at postoperative 1 year. Secondary
      outcomes are improvement or remission rates of obesity-related co-morbidity (hypertension,
      type 2 diabetes, dyslipidemia, and sleep apnea), and the change in quality of life.
      Additionally, postoperative incidences of morbidity and mortality, micronutrient status, body
      composition, and cost-effectiveness of surgical intervention will be examined.
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>body weight (cm) change</measure>
    <time_frame>postoperative 1-year</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>waist circumference (cm) change</measure>
    <time_frame>postoperative 1-year</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>remission rates of obesity-related co-morbidity (hypertension, type 2 diabetes, dyslipidemia, and sleep apnea)</measure>
    <time_frame>postoperative 1-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Quality of life change</measure>
    <time_frame>postoperative 1-year</time_frame>
    <description>EuroQol-5D (EQ-5D), the impact of weight on QoL (IWQOL) and the obesity-related psychosocial problem scale (OP-scale) are used to assess the improvement of QoL</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Morbidity</measure>
    <time_frame>postoperative 1-year</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Mortality</measure>
    <time_frame>postoperative 1-month</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Micronutrients' deficiency</measure>
    <time_frame>postoperative 1-year</time_frame>
    <description>iron, ferritin, calcium, phosphate, albumin, vit.B12, vit.D, and parathyroid hormone</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>body composition change</measure>
    <time_frame>postoperative 1-year</time_frame>
    <description>bioelectrical impedance analysis and fat measurement CT</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>cost-effectiveness</measure>
    <time_frame>postoperative 1-year</time_frame>
    <description>cost-utility analysis using lifetime expected costs and quality-adjusted life years (QALYs)</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Bariatric Surgery Candidate</condition>
  <condition>Obesity, Morbid</condition>
  <arm_group>
    <arm_group_label>bariatric surgery</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>This trial is a single-arm study and the enrolled patients are going to undergo sleeve gastrectomy (SG) or Roux-en-Y gastric bypass (RYGB).
If the patient has Barrett's esophagus on the preoperative endoscopy, SG is not permitted. Inflammatory bowel disease and Helicobacter pylori infection on a rapid urease test are contraindications of RYGB.</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>Sleeve gastrectomy or Roux-en-Y gastric bypass</intervention_name>
    <arm_group_label>bariatric surgery</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. body mass index (BMI) ≥ 35 kg/m2 or BMI ≥ 30 kg/m2 with co-morbidities such as
             hypertension, glucose intolerance, dyslipidemia, and sleep apnea

          2. being suitable for general anesthesia

          3. being able to give informed consent and committed to follow-up

          4. Female patients should have a negative urine pregnancy test at screening and agree to
             use reliable method of contraception for 1 year.

        Exclusion Criteria:

          1. prior bariatric surgery of any kind

          2. being unable to understand the risks, benefits and compliance requirements of this
             trial

          3. pregnancy or planning on being pregnancy

          4. non-Korean speaker

          5. American society of anesthesiology (ASA) class IV or higher

          6. malignancy within 5 years.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>20 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Young Suk Park, M.D.</last_name>
    <phone>+82-31-787-7099</phone>
    <email>selteenzeus@gmail.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Do Joong Park, M.D., Ph.D.</last_name>
    <phone>+82-31-787-7099</phone>
    <email>dojoongpark@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Bundang Hospital</name>
      <address>
        <city>Seongnam</city>
        <state>Gyeonggi-do</state>
        <zip>13620</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Young Suk Park, M.D.</last_name>
      <phone>+82-31-787-7099</phone>
      <email>selteenzeus@gmail.com</email>
    </contact>
    <contact_backup>
      <last_name>Do Joong Park, M.D., Ph.D.</last_name>
      <phone>+82-31-787-7099</phone>
      <email>dojoongpark@gmail.com</email>
    </contact_backup>
    <investigator>
      <last_name>Yoon-Seok Heo, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Hyuk-Joon Lee, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sang-Moon Han, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Joo Ho Lee, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sang-Uk Han, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seung Wan Ryu, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Moon-Won Yoo, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Seung Ho Choi, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tae Kyung Ha, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sung-Soo Park, M.D., Ph.D.</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>March 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 23, 2017</study_first_submitted>
  <study_first_submitted_qc>April 3, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">April 4, 2017</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 4, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Seoul National University Bundang Hospital</investigator_affiliation>
    <investigator_full_name>Do Joong Park</investigator_full_name>
    <investigator_title>Professor</investigator_title>
  </responsible_party>
  <keyword>primary bariatric surgery</keyword>
  <keyword>morbid obesity</keyword>
  <keyword>South Korea</keyword>
  <keyword>sleeve gastrectomy</keyword>
  <keyword>Roux-en Y gastric bypass</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Obesity</mesh_term>
    <mesh_term>Obesity, Morbid</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

